Clarity Pediatrics Announces Expansion of Virtual Pediatric ADHD Platform and $10M in Funding

Over 400 California pediatricians are already referring commercial and Medicaid patients to Clarity for comprehensive virtual ADHD care

SAN FRANCISCO, CA — April 22, 2024 — Clarity Pediatrics, a digital health company reimagining pediatric chronic care, announced today the expansion of their pediatric ADHD platform and $10M in seed funding led by Rethink Impact with participation from Homebrew and Maverick Ventures. This investment supports Clarity Pediatrics’ launch of new clinical service lines, further development of their innovative care platform, and geographic expansion.

Nearly one in ten American children have ADHD, impacting their relationships, self-confidence, and performance at school. The cornerstone of Clarity Pediatrics’ approach to ADHD care is Behavioral Parent Training (BPT), recommended by the American Academy of Pediatrics for families of children ages 5 to 12 with mild-moderate ADHD. Unfortunately, 80% of children with ADHD don’t have access to BPT, and most families wait over a year and pay $3,000 or more out of pocket to get access to ADHD treatment. Clarity Pediatrics makes pediatric ADHD care 10x more accessible and 20x more affordable: families have access to next-day appointments, including for ADHD diagnostic screening and medication-related services, and pay an average co-pay of $15 per session.

“Our ADHD care model is transformative for families. Clarity Pediatrics integrates with referring pediatricians, so families stay close to their doctor and physicians get additional support. We’ve made the impossible now possible for thousands of families experiencing ADHD: affordable, expert diagnosis and multi-specialty treatment, coordinated on a single convenient platform, with no waitlists” said CEO and co-founder Christina LaMontagne. Prior to leading Clarity Pediatrics, Christina was on the leadership team of two startups in the healthcare and fintech sectors that successfully reached >$100M in ARR and profitability.

With Clarity’s newly expanded ADHD care platform, families can now enroll in twelve months of virtual group therapy support via skill building programs designed to address executive function challenges (e.g. homework organizational skills) and emotional dysregulation. Clarity also recently launched medication management for pediatric ADHD.

In less than eighteen months of providing clinical care to thousands of families in California, Clarity Pediatrics has established a reputation for delivering high-quality and effective ADHD care. Clarity Pediatrics is in-network with all major commercial insurers in California, and more than 400 pediatricians across the state have referred patients to Clarity, including clinicians affiliated with all major California health systems. Families who complete Clarity’s BPT program report that:

• 88% of families said Clarity’s BPT program helped their understanding of ADHD and parenting
• 83% of families said it helped reduce challenging behaviors
• 89% of families agree they got care faster with Clarity than other options

“Clarity’s rapid growth, coupled with exceptional parent feedback and patient outcomes, got us very excited. Dr. Alesandro Larrazabal and Christina LaMontagne really understand tech-enabled healthcare, and we were impressed by how quickly payers and providers partnered with them. I’ve known Christina for over ten years and can’t think of a more experienced and insightful leader to build a category-defining company that closes the pediatric chronic care gap for good,” said Heidi Patel, Managing Partner at Rethink Impact.

Clarity Pediatrics was co-founded by Dr. Alesandro Larrazabal, an experienced pediatric specialist who trained at UCSF and Stanford, and, until recently, was a Medical Director building specialty care services at Kaiser Permanente. “For us, it’s essential to provide care to all families. In 2023, we welcomed our first Medicaid-enrolled patients and launched a Spanish-language pilot,” said Dr. Larrazabal, who serves as Chief Medical Officer. “The prevalence of pediatric chronic conditions has tripled, and we’re building our virtual care platform to expand beyond ADHD to other common pediatric chronic conditions like asthma, allergies, and obesity.”

The seed round also included investments from January Ventures, Vamos Ventures, Alumni Ventures and Citylight VC. These institutional investors join a robust set of angel investors who are healthcare leaders at CityBlock, Quartet, Livongo, Headspace (Ginger), Rock Health, Solv and more.